These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36790492)

  • 41. Moyamoya angiopathy: long-term follow-up study in a Finnish population.
    Savolainen M; Mustanoja S; Pekkola J; Tyni T; Uusitalo AM; Ruotsalainen S; Poutiainen E; Hernesniemi J; Kivipelto L; Tatlisumak T
    J Neurol; 2019 Mar; 266(3):574-581. PubMed ID: 30560456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seizures in Pediatric Moyamoya: Risk Factors and Functional Outcomes.
    Gatti JR; Penn R; Ahmad SA; Sun LR
    Pediatr Neurol; 2023 Aug; 145():36-40. PubMed ID: 37271055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin use and platelet aggregation in ischemic onset-type pediatric moyamoya patients with intractable headaches (moya-ache).
    Aihara Y; Kashiwase S; Chiba K; Yamaguchi K; Okada Y; Kimura T; Kawamata T
    Childs Nerv Syst; 2021 May; 37(5):1649-1657. PubMed ID: 33404716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery.
    So Y; Lee HY; Kim SK; Lee JS; Wang KC; Cho BK; Kang E; Lee DS
    Stroke; 2005 Jul; 36(7):1485-9. PubMed ID: 15947261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological features of moyamoya disease in Japan.
    Hoshino H; Izawa Y; Suzuki N;
    Neurol Med Chir (Tokyo); 2012; 52(5):295-8. PubMed ID: 22688065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and clinical features of disease progression in adult moyamoya disease.
    Kuroda S; Ishikawa T; Houkin K; Nanba R; Hokari M; Iwasaki Y
    Stroke; 2005 Oct; 36(10):2148-53. PubMed ID: 16179571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Encephaloduroarteriosynangiosis for Pediatric Moyamoya Disease: A Single-Center Experience With 67 Cases in China.
    Wang C; Zhao M; Wang J; Wang S; Zhang D; Wang K; Zhao J
    J Child Neurol; 2018 Dec; 33(14):901-908. PubMed ID: 30246586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
    Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
    J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Moyamoya disease: current concepts and future perspectives.
    Kuroda S; Houkin K
    Lancet Neurol; 2008 Nov; 7(11):1056-66. PubMed ID: 18940695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asymptomatic moyamoya disease: literature review and ongoing AMORE study.
    Kuroda S;
    Neurol Med Chir (Tokyo); 2015; 55(3):194-8. PubMed ID: 25739434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of Moyamoya Disease Based on National Registry Data in Japan.
    Sato Y; Kazumata K; Nakatani E; Houkin K; Kanatani Y
    Stroke; 2019 Aug; 50(8):1973-1980. PubMed ID: 31234758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of Conservative Follow-up or Surgical Treatment of Moyamoya Patients Who Present without Hemorrhage, Transient Ischemic Attack, or Stroke.
    Luo R; Gao F; Deng X; Zhang D; Zhang Y
    World Neurosurg; 2017 Dec; 108():683-689. PubMed ID: 28927919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease.
    Funaki T; Takahashi JC; Miyamoto S
    Neurol Med Chir (Tokyo); 2018 Jun; 58(6):240-246. PubMed ID: 29780072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease.
    Han DH; Kwon OK; Byun BJ; Choi BY; Choi CW; Choi JU; Choi SG; Doh JO; Han JW; Jung S; Kang SD; Kim DJ; Kim HI; Kim HD; Kim MC; Kim SC; Kim SC; Kim Y; Kwun BD; Lee BG; Lim YJ; Moon JG; Park HS; Shin MS; Song JH; Suk JS; Yim MB;
    Acta Neurochir (Wien); 2000; 142(11):1263-73; discussion 1273-4. PubMed ID: 11201642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features, course, and outcomes of a UK cohort of pediatric moyamoya.
    Tho-Calvi SC; Thompson D; Saunders D; Agrawal S; Basu A; Chitre M; Chow G; Gibbon F; Hart A; Tallur KK; Kirkham F; Kneen R; McCullagh H; Mewasingh L; Vassallo G; Vijayakumar K; Wraige E; Yeo TH; Ganesan V;
    Neurology; 2018 Feb; 90(9):e763-e770. PubMed ID: 29483323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical presentation, progression, and treatment outcomes of moyamoya disease in the elderly.
    Gupta R; M Moore J; Adeeb N; Griessenauer CJ; Patel AS; Chua MH; Thomas AJ; Ogilvy CS
    Acta Neurochir (Wien); 2016 Dec; 158(12):2409-2414. PubMed ID: 27757556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease.
    Araki Y; Yokoyama K; Uda K; Kanamori F; Mamiya T; Nishihori M; Sumitomo M; Okamoto S; Izumi T
    Acta Neurochir (Wien); 2021 May; 163(5):1493-1502. PubMed ID: 33624115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.
    Strother MK; Anderson MD; Singer RJ; Du L; Moore RD; Shyr Y; Ladner TR; Arteaga D; Day MA; Clemmons PF; Donahue MJ
    AJNR Am J Neuroradiol; 2014 Jul; 35(7):1318-24. PubMed ID: 24651814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.